http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13986662

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural
endingPage e472
issn 0031-4005
1098-4275
issueIdentifier 3
pageRange e466-e472
publicationName Pediatrics
startingPage e466
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_23b5a837dddab85ba3b41fbf7fcf0f71
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_649203d8d3a221bb6757b0cec753d2ed
bibliographicCitation Hassan K, Rodriguez LM, Johnson SE, Tadlock S, Heptulla RA. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes. Pediatrics. 2008 Mar;121(3):e466–72. doi: 10.1542/peds.2007-1679. PMID: 18299307.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93a8f6ed65a0009f4d2ec37a0f53492f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fab1d3a0d9b325a0c310b3487b2cffba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54747d64c8b4846990fc26fdab2bcc39
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e42d8f0682dc5cb650d4815ea9b2959b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9dbfa1d59810948a1b90f9131cf9850
date 2008-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/18299307
https://doi.org/10.1542/peds.2007-1679
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6405
https://portal.issn.org/resource/ISSN/1098-4275
https://portal.issn.org/resource/ISSN/0031-4005
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A Randomized, Controlled Trial Comparing Twice-a-Day Insulin Glargine Mixed With Rapid-Acting Insulin Analogs Versus Standard Neutral Protamine Hagedorn (NPH) Therapy in Newly Diagnosed Type 1 Diabetes
discusses http://id.nlm.nih.gov/mesh/M0002696
http://id.nlm.nih.gov/mesh/M0011436
http://id.nlm.nih.gov/mesh/M0011417
http://id.nlm.nih.gov/mesh/M0465327
http://id.nlm.nih.gov/mesh/M0361589
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D007328Q000031
http://id.nlm.nih.gov/mesh/D049528Q000008
http://id.nlm.nih.gov/mesh/D003922Q000188
http://id.nlm.nih.gov/mesh/D003922Q000175
http://id.nlm.nih.gov/mesh/D007336Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D001786Q000032
http://id.nlm.nih.gov/mesh/D012016
http://id.nlm.nih.gov/mesh/D007003Q000517
http://id.nlm.nih.gov/mesh/D012720
http://id.nlm.nih.gov/mesh/D011788
http://id.nlm.nih.gov/mesh/D018570
http://id.nlm.nih.gov/mesh/D005500
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D015190
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D002648
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000069036
http://id.nlm.nih.gov/mesh/D007279
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D007328Q000008
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D011336
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7442
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1ef7af3407e96ea02497b2009be8786
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433

Total number of triples: 68.